Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients

NCT02740426 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Upper Tract Urothelial Carcinoma
Bladder Recurrence

Interventions

DRUG: Pirarubicin

Sponsor

Peking University First Hospital